Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinoway is a prominent Chinese pharmaceutical company that has specialized in the development and supply of Active Pharmaceutical Ingredients (APIs) and intermediates since 1987. The company operates as an integrated CDMO and CRO, providing services ranging from custom synthesis and process optimization to large-scale commercial manufacturing. Their product portfolio covers a diverse array of therapeutic areas, including oncology, cardiovascular disease, and infectious diseases, with a specialized focus on peptide chemistry. Sinoway serves a global clientele, maintaining rigorous quality standards and participating in major international industry events like CPhI. The company also offers solutions for the health supplement and cosmetic industries, leveraging its chemical expertise to provide high-purity ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinoway.